Luc Wasungu

2.4k total citations · 1 hit paper
22 papers, 1.8k citations indexed

About

Luc Wasungu is a scholar working on Molecular Biology, Biotechnology and Biomedical Engineering. According to data from OpenAlex, Luc Wasungu has authored 22 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Biotechnology and 10 papers in Biomedical Engineering. Recurrent topics in Luc Wasungu's work include Microbial Inactivation Methods (11 papers), Microfluidic and Bio-sensing Technologies (10 papers) and RNA Interference and Gene Delivery (5 papers). Luc Wasungu is often cited by papers focused on Microbial Inactivation Methods (11 papers), Microfluidic and Bio-sensing Technologies (10 papers) and RNA Interference and Gene Delivery (5 papers). Luc Wasungu collaborates with scholars based in France, Netherlands and Poland. Luc Wasungu's co-authors include Dick Hoekstra, Marie‐Pierre Rols, Justin Teissié, Jean‐Michel Escoffre, Jan B. F. N. Engberts, Bernard Chevalier, Yoshinobu Onuma, Thomas Portet, David S. Dean and Susan Veldhof and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and Biochemical Journal.

In The Last Decade

Luc Wasungu

21 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

2014 393 citations Patrick W. Serruys, Bernard Chevalier et al. The Lancet profile →

Peers

Countries citing papers authored by Luc Wasungu

Since Specialization

Citations

This map shows the geographic impact of Luc Wasungu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luc Wasungu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luc Wasungu more than expected).

Fields of papers citing papers by Luc Wasungu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luc Wasungu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luc Wasungu. The network helps show where Luc Wasungu may publish in the future.

Co-authorship network of co-authors of Luc Wasungu

This figure shows the co-authorship network connecting the top 25 collaborators of Luc Wasungu. A scholar is included among the top collaborators of Luc Wasungu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luc Wasungu. Luc Wasungu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis 2016 ·Journal of the American College of Cardiology ·Patrick W. Serruys, John Ormiston, Robert‐Jan van Geuns, Bernard De Bruyne, Dariusz Dudek, Evald Høj Christiansen, Bernard Chevalier, Pieter Smits, Dougal McClean, Jacques Koolen, Stephan Windecker, Robert Whitbourn, Ian T. Meredith, Luc Wasungu, Divine Ediebah, Susan Veldhof, Yoshinobu Onuma	119
2	Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial 2016 ·EuroIntervention ·Bernard Chevalier, Yoshinobu Onuma, Ad J. van Boven, Jan J. Piek, Manel Sabaté, Steffen Helqvist, Andreas Baumbach, Pieter C. Smits, (unknown), Luc Wasungu, Patrick W. Serruys	42
3	Drug Release by Direct Jump from Poly(ethylene-glycol-b-ε-caprolactone) Nano-Vector to Cell Membrane 2016 ·Molecules ·(unknown), Laure Gibot, Anne‐Françoise Mingotaud, (unknown), Luc Wasungu, Christophe Mingotaud, Jean‐Pierre Souchard, (unknown), Marie‐Pierre Rols, Frédéric Violleau, Patricia Vicendo	11
4	TCT-11 Five-year Follow up of the First in Man use of a Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis; A Serial Multi-Imaging Modality Study 2015 ·Journal of the American College of Cardiology ·Patrick W. Serruys, Yoshinobu Onuma, Robert J. Van Geuns, Bernard De Bruyne, Dariusz Dudek, Evald Høj Christiansen, Bernard Chevalier, Pieter C. Smits, Dougal McClean, Jacques Koolen, Stephan Windecker, Robert Whitbourn, Ian T. Meredith, Luc Wasungu, Divine Ediebah, Susan Veldhof, John A. Ormiston	0
5	Shock waves associated with electric pulses affect cell electro-permeabilization 2014 ·Bioelectrochemistry ·Luc Wasungu, Flavien Pillet, Elisabeth Bellard, Marie‐Pierre Rols, Justin Teissié	13
6	A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial breakdown → 2014 ·The Lancet ·Patrick W. Serruys, Bernard Chevalier, Dariusz Dudek, Ángel Cequier, Didier Carrié, Andrés Íñiguez, Marcello Dominici, René J. van der Schaaf, Michael Haude, Luc Wasungu, Susan Veldhof, Lei Peng, Peter Stæhr, Maik J. Grundeken, Yuki Ishibashi, Héctor M. García‐García, Yoshinobu Onuma	393
7	Antitumor drug delivery in multicellular spheroids by electropermeabilization 2013 ·Journal of Controlled Release ·Laure Gibot, Luc Wasungu, Justin Teissié, Marie‐Pierre Rols	59
8	Investigating relationship between transfection and permeabilization by the electric field and/or the Pluronic® L64 in vitro and in vivo 2012 ·The Journal of Gene Medicine ·Michel F. Bureau, Luc Wasungu, Lauriane Jugé, Daniel Scherman, Marie‐Pierre Rols, Nathalie Mignet	3
9	Drug delivery by electropulsation: Recent developments in oncology 2011 ·International Journal of Pharmaceutics ·Justin Teissié, Jean‐Michel Escoffre, (unknown), Sophie Chabot, Elisabeth Bellard, Luc Wasungu, Marie‐Pierre Rols, Muriel Golzio	29
10	Pre-treatment of cells with pluronic L64 increases DNA transfection mediated by electrotransfer 2010 ·Journal of Controlled Release ·Luc Wasungu, (unknown), M. Bureau, Antoine Kichler, Michel Bessodes, Justin Teissié, Daniel Scherman, Marie‐Pierre Rols, Nathalie Mignet	9
11	Cationic and anionic lipoplexes inhibit gene transfection by electroporation in vivo 2010 ·The Journal of Gene Medicine ·Nathalie Mignet, Gaëlle Vandermeulen, Gaëlle Pembouong, Céline Largeau, Betty Thompson, (unknown), Luc Wasungu, Marie‐Pierre Rols, Michel Bessodes, Michel F. Bureau, Véronique Préat, Daniel Scherman	9
12	Gene electrotransfer: from biophysical mechanisms to in vivo applications 2009 ·Biophysical Reviews ·Jean‐Michel Escoffre, (unknown), Thomas Portet, Luc Wasungu, (unknown), Muriel Golzio, Justin Teissié, Marie‐Pierre Rols	2
13	A 3D in vitro spheroid model as a way to study the mechanisms of electroporation 2009 ·International Journal of Pharmaceutics ·Luc Wasungu, Jean‐Michel Escoffre, Annie Valette, Justin Teissié, Marie‐Pierre Rols	38
14	Gene electrotransfer: from biophysical mechanisms to in vivo applications 2009 ·Biophysical Reviews ·Jean‐Michel Escoffre, (unknown), Thomas Portet, Luc Wasungu, (unknown), (unknown), (unknown), Elisabeth Bellard, Muriel Golzio, Marie‐Pierre Rols, Justin Teissié	9
15	Gene delivery by cationic lipids: in and out of an endosome 2007 ·Biochemical Society Transactions ·Dick Hoekstra, Joanna Rejman, Luc Wasungu, F. Shi, Inge S. Zuhorn	146
16	Lipoplexes formed from sugar-based gemini surfactants undergo a lamellar-to-micellar phase transition at acidic pH. Evidence for a non-inverted membrane-destabilizing hexagonal phase of lipoplexes 2006 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Luc Wasungu, Marc C. A. Stuart, (unknown), Jan B. F. N. Engberts, Dick Hoekstra	52
17	Transfection mediated by pH-sensitive sugar-based gemini surfactants; potential for in vivo gene therapy applications 2006 ·Journal of Molecular Medicine ·Luc Wasungu, (unknown), (unknown), Grietje Molema, Anno Wagenaar, Jan B. F. N. Engberts, Dick Hoekstra	48
18	Cationic lipids, lipoplexes and intracellular delivery of genes 2006 ·Journal of Controlled Release ·Luc Wasungu, Dick Hoekstra	473
19	Interference of poly(ethylene glycol)–lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions 2002 ·Biochemical Journal ·Fuxin Shi, Luc Wasungu, Anita Nomden, Marc C. A. Stuart, Evgeny Polushkin, Jan B. F. N. Engberts, Dick Hoekstra	127
20	A radiation hybrid map of the RN region in pigs demonstrates conserved gene order compared with the human and mouse genomes 1999 ·Mammalian Genome ·Annie Robic, (unknown), (unknown), Martine Yerle, Luc Wasungu, Leif Andersson, Joël Gellin, Denis Milan	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact